Peter M Hecht is of Cyclerion Therapeutics, Inc.. Currently has a direct ownership of 377,385 shares of CYCN, which is worth approximately $660,423. The most recent transaction as insider was on Jan 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 377K
0% 3M change
15.27% 12M change
Total Value Held $660,423

Peter M Hecht Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 3.82%
377,385 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
-
15,000 Added 3.97%
362,385 Common Stock
Nov 30 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 5.44%
347,385 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
$1,953,000 $8.68 p/Share
225,000 Added 40.73%
327,385 Common Stock
Jun 03 2021
BUY
Open market or private purchase
$2,699,998 $3.28 p/Share
823,170 Added 28.67%
2,047,698 Common Stock
May 06 2021
BUY
Open market or private purchase
$733,860 $2.43 p/Share
302,000 Added 19.78%
1,224,528 Common Stock
May 05 2021
BUY
Open market or private purchase
$1,006,943 $2.53 p/Share
398,001 Added 30.14%
922,528 Common Stock
May 04 2021
BUY
Open market or private purchase
$687,000 $2.29 p/Share
300,000 Added 36.38%
524,527 Common Stock
PMH

Peter M Hecht

Cambridge, MA

Track Institutional and Insider Activities on CYCN

Follow Cyclerion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCN shares.

Notify only if

Insider Trading

Get notified when an Cyclerion Therapeutics, Inc. insider buys or sells CYCN shares.

Notify only if

News

Receive news related to Cyclerion Therapeutics, Inc.

Track Activities on CYCN